Assuming key BP people were in attendance at Dr White's presentation and with many of the BP looking at a revenue cliff they would have to be suitably impressed by MPL's results especially as they were analyzed, prepared and presented by Berry Consultants, independent consulting statisticians who presented the most conservative case.
Not sure BP can just walk away from such a potential revenue blockbuster even though P1 only had 12 patients
Ann: PharmAust's Phase 1 Study Data Presented at Major Conference, page-16
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $89.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 175242 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.13pm 19/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |
Day chart unavailable